Human Immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS), also manifests neurological complications. HIVassociated dementia (HAD) is the most severe form of HIV-induced neurocognitive disorders. HIV encephalitis (HIVE), the pathological correlate of HAD, is characterized by the formation of multinucleated giant cells and microglial nodules, astrocytosis, and neuronal damage and loss. Pathological evaluation of HAD disease progression in humans is not possible, with the only data collected being from individuals who have succumbed to the disorder, a snap shot of end-stage disease at best. Therefore, pertinent animal models have been developed to alleviate this gap of knowledge in the field of neurovirology and neuroinflammation. In general, the most widely used animal models are the simian immunodeficiency virus (SIV) and the chimeric simian/human immunodeficiency virus (SHIV) macaque model systems. Although both SIV and SHIV model systems are able to potentiate neuroinvasion and the concomitant neuropathology similar to that seen in the human syndromes, the innate differences between the two in disease pathogenesis and progression make for two separate, yet effective, systems for the study of HIV-associated neuropathology.
infection in, and elimination of, the CD4 + T-cell population, leading to a loss of cell-mediated immune (CMI) responses and Th1 cytokines, such as interleukin (IL)-2 and interferon (IFN)-γ (Dalgleish, 1995) . The lack of these responses is associated with two phenomena: first, development of selected tumors and proliferation of opportunistic pathogens in different organ systems of the body (Barker, 1995; Orenstein et al, 1997; Liu et al, 1999) , and second, progressive viral replication in specific tissues such as the brain (Gendelman et al, 1994; Orenstein et al, 1997; Igarashi et al, 2001) . Unlike other viral infections in the brain, HIV-1 infection in the central nervous system (CNS) is centered around viral replication in cells of macrophage lineage (Gendelman et al, 1994) , which correlates with development of encephalitis and dementia.
The early phase of HIV infection is dominated by highly productive viral replication in the lymph nodes. This results in massive viremia and loss of cells bearing the CD4 phenotype (Levy, 1993; Schnittman and Fauci, 1994) . At this stage mononuclear cells in the blood are activated and
CD4
+ T cells are productively infected in the presence of Th1 cytokines (Clerici et al, 1994; Clerici and Shearer, 1993) . Large numbers of monocytes are also infected in this stage, but macrophages derived from these cells show only minimal viral productivity. Although HIV appears in the cerebrospinal fluid (CSF) during this phase of the infection (Gabuzda and Sobel, 1987) , the nature of the infection in the CNS is not known. Whether the presence of virus in the CSF/CNS results from trafficking activated, infected CD4 + T cells, monocytes, or dendritic cells (DCs) from periphery is not known. Activated, infected CD4
+ T cells are probably important for this event because molecularly cloned macrophagetropic SIV mac viruses are poorly neuroinvasive (Lackner et al, 1994) . Further, the prototypic lentivirus infection-visna virus infection-in sheep, which is strictly macrophage tropic, is not neuroinvasive (Chebloune et al, 1998) , even though the virus is highly neurovirulent when injected intracerebrally (Craig et al, 1997) .
Following the early phase of activation and infection, which is accompanied by increased virus production by the CD4 + T cells, subsequent progressive elimination of these cells occurs due to the viral cytopathic effects. Antiviral CMI responses of the Th1 type develop and initially reduce virus replication, but fail to eliminate the agent. The continued loss of CD4 + T cells inevitably results in the loss of the Tcell response required for driving the CMI responses. This leads to the collapse of the cellular arm of the immune response and the loss of immunocompetence. The Th2 arm of the immune system remains intact and frequently becomes activated when opportunistic pathogens begin to proliferate in the void of Th1 responsiveness. These pathogens include certain protozoa, viruses, mycotic agents, and intracellular bacteria, such as the mycobacterium species. Macrophages induced by these pathogens often become the target for viral replication in whatever tissue the parasites proliferate; this includes the CNS.
Productive viral replication in the CNS coincides with the severe loss of T-cell function. HIV-associated dementia (HAD) is a clinical disorder characterized by progressive cognitive, motor, and behavioral abnormalities (Navia et al, 1986) caused by HIV-1 infection. Prominent neurological disease occurs in 15% to 20% (McArthur et al, 1999) of infected individuals and is associated with a marked depletion of CD4 + T lymphocytes (Glass et al, 1995; Michaels et al, 1988; Wiley et al, 1986) . HIV-1 encephalitis (HIVE), a common pathological manifestation of HAD, includes the infiltration of macrophages into brain where they become productively infected with the virus. This is accompanied by massive cytokine (Poli et al, 1995) and chemokine dysregulation in the brain, which often culminates into the unique neuropathology belonging to this syndrome. Characteristic pathological changes of HIVE include perivascular accumulations of mononuclear cells, formation of microglial nodules and multinucleated giant cells, activation and proliferation of astrocytes, and neuronal dysfunction and loss (Bell, 1998; Gendelman et al, 1994; Nath, 1999) . Productive infection of macrophages and microglial cells is believed to contribute to pathological changes in neurons through secretion of viral (gp120, Tat, and Nef) and cellular (cytokines, chemokines, and nitric oxide) neurotoxic products (Kolson and Pomerantz, 1996; Lipton and Gendelman, 1995) .
The mechanism of late onset of the neurological complications in HIV-infected individuals is puzzling because the virus can enter the CNS within days of primary infection. It remains unclear (a) whether neurological complications are due to virus reactivation during the late stage of infection; (b) whether there is a renewed phase of viral neuroinvasion in late stage disease; or (c) whether the virus is continuously replicating in the CNS at low levels. Although studies on humans with HIV-CNS disease have contributed significantly to our understanding of the pathogenesis of HAD, they only generate snapshots of the disease end point. This creates a need for an animal-model system that will accurately reproduce the pathogenesis of HIV infection. However, HIV does not cause disease in animals, therefore the questions of neuropathogenesis have to be relegated to studies in macaques infected with simian immunodeficiency virus (SIV) and chimeras of SIV and HIVSHIVs Lackner et al, 1991 Lackner et al, , 1994 . SIV infection in macaques has provided excellent models of HIV encephalopathy Lackner et al, 1991 Lackner et al, , 1994 . Pathogenic chimeric SHIVs, which have the envelope of HIV-1 (HXB2) on a background of SIV mac 239, have also provided additional working models of HIV neurological disease. These chimeric viruses provide a unique opportunity to examine the effect of the HIV-1 envelope on the biology of the virus in the brain within the context of neurological disease. In the following sections we will discuss each of the model systems and their advantages and/or limitations as it relates to the study of NeuroAIDS in humans.
SIV infection in macaques
Most studies on the neuropathogenesis of SIV infection in macaques have been performed with the strains SIV mac 239 and SIV mac 251 (Lackner et al, 1994; Luciw et al, 1992; Smith et al, 1995) .These viruses use both the CD4 and CCR5 receptors for entry into host cells (Edinger et al, 1997; Kirchhoff et al, 1997; Weissman et al, 1997) . Both SIVs cause acute infections characterized by cell-associated and cell-free viremia. Virus-infected cells can be found in the CSF throughout the acute phase, which can last for 2 to 10 weeks (Joag et al, 1994; Sharma et al, 1992a Sharma et al, , 1992b . During this phase, infection in the CNS is characterized by meningitis and accumulations of mononuclear cells in the Virchow-Robin spaces in the brain. Virus-infected macrophages have also been identified in these exudate cells (Lackner et al, 1991; Lane et al, 1996) . Lesions caused by SIV mac 239 are less severe and do not involve the neuropil. Instead, meningitis disappears at the end of the acute, systemic phase of infection (Joag et al, 1994; Lackner et al, 1994) , and viral DNA, demonstrable by polymerase chain reaction (PCR), provides the only record of the antecedent infection in the brain (Stephens et al, 1995) . The failure of the virus to cause progressive CNS infection could be attributable to its inability to replicate in macrophages .
Studies on SIV infection in macaques have shown that in all cases of encephalopathy, viral replication in macrophages in brain (identified by in situ hybridization and immunohistochemistry) correlated with the ability of the virus to replicate productively in cultured macrophages derived from peripheral blood of animals of the affected species. Examples of these are SIV/17E-Fr (Zink et al, 1997) and SIVsmmFGb infection in pig-tailed macaques (Bucur et al, 1998) . These assays confirmed that the potential for causing encephalitis required that the virus be capable of replicating in activated CD4
+ T cells and in macrophages, and that viruses incapable of replication in macrophages were incapable of causing encephalitis (Lackner et al, 1994; Sharma et al, 1992b) . These viruses all utilize the CCR5 coreceptor for entry into susceptible cells, but it is of interest that other strains of SIV that also use the CCR5 coreceptor and were incapable of causing encephalopathy were also incapable of replicating productively in peripheral blood mononuclear cell (PBMC)-derived macrophages .
SIV mac 251 is a dual-tropic virus, capable of replicating productively in CD4 + T lymphocytes and macrophages Wu et al, 1996) . During the acute phase of infection caused by this virus, viral neuroinvasion and meningitis develop in a pattern identical to that observed with SIV mac 239 (Chakrabarti et al, 1991; Lackner et al, 1994; Luciw et al, 1992; Smith et al, 1995) ; however, the SIV mac 251 infection progresses to involve the neuropil. Similar to the human syndrome, astrocytes and microglia also become activated, the latter frequently undergoing proliferation, resulting in nodular accumulations da Cunha et al, 1997; Saito et al, 1994; Sharer et al, 1994 Sharer et al, , 1996 . Encephalitic changes, involving dense infiltrations of mononuclear cells, develop in both gray and white matter with the spread of mononuclear inflammatory cells from perivascular locations into the brain substance . Multinucleated giant cells occur frequently among the inflammatory cells and there is extensive viral replication in macrophages. Unlike the human syndrome, in SIV mac 251-infected macaques, inflammatory lesions in the meninges and neuropil occur in the presence of relatively normal numbers of CD4 + T lymphocytes in peripheral blood, although CD4
+ T cells frequently "crash" during progressive neurological disease .
These histopathological changes progress continuously in animals that fail to develop antiviral immune responses. Furthermore, unlike the human CNS disease, SIV lesions in the CNS are much more severe compared with those seen in HIV-infected brains. These differences can be attributed to the natural history of HIV infection in which CD4 + T cells are lost prior to development of neurological symptoms, whereas in macaques, the CD4 + T cells may contribute to the development of lesions.
As opposed to infected animals that fail to develop immune responses and succumb to neurological disease, some infected macaques that develop CMI responses to the virus following acute phase of infection will also control systemic and CNS viral replication (Kuroda et al, 1999) . However, treatment of such animals with antibodies to CD8 + T cells abolished the cytotoxic T-lymphocyte (CTL) response, resulting in the onset of neurological disease accompanied by productive virus replication in the brain (Matano et al, 1998; Schmitz et al, 1999a) . These findings led to the suggestion that lesions that might have developed during acute infection underwent resolution, concomitant with CTL-mediated retrenchement of viral replication in the lymphoid system and the brain. Following elimination of CTLs with antibodies, viral recrudescence developed in the brain.
Macaques infected with SIV mac 182 have also aided in our understanding of how virus-host interactions contribute to the related CNS functional defects. In this model, SIV-specific CD8 + CTLs were discovered in the CSF of infected macaques very early after infection and in the brain at necropsy (Marcondes et al, 2007) . This model has been used to explore the impact of immune responses in mediating CNS injury and was exploited to evaluate the brain infiltrate and the phenotype of T cells in the CNS compared with those in the periphery, at a relatively early stage of SIV-induced disease. It has been elegantly demonstrated that SIV mac 251-infected macaques have altered evoked potentials, a drastic increase in the number of activated CD8 + T cells expressing predominantly a memory and a cytolytic phenotype and a unique cytokine milieu in the brains during early SIV infection. These findings suggest that SIV infection induces a chronic immune response in the CNS that mediates injury to the brain (Marcondes et al, 2001 (Marcondes et al, , 2003 (Marcondes et al, , 2007 .
Although the SIV-infected macaque model of neuro AIDS best recapitulates HIV neuropathogenesis, there are limitations with this model. For one, similar to the human scenario, not all infected macaques predictably develop CNS disease, in fact the percentage of animals developing SIV encephalitis (SIVE) is only 25%. Secondly, the prolonged progression (1 to 3 years) towards development of AIDS further limits its usefulness. This has led to the development of two additional accelerated macaque models that overcome the barriers of low incidence of SIVE and prolonged time to disease pathogenesis (Schmitz al, 1999b; Zink et al, 1997 Zink et al, , 1999 . One of these models developed by Zink et al uses pigtailed macaques coinoculated intravenously with a combination of two viruses: SIV/17E-Fr, a neurovirulent molecular clone, and SIV/DeltaB670, an immunosuppressive and neurovirulent virus swarm (Clements et al, 2002; Craig et al, 1997; Zink et al, 1999) . Infection with these viruses leads to predictable CD4 + T-lymphocyte depletion and highly efficient replication in CNS macrophages within 3 months post inoculation in almost 90% of inoculated macaques. This highly reproducible and predictable model of neuro AIDS has proven extremely valuable in exploring the host and viral events in the CNS during acute infection and during the subsequent development of SIVE. In this model, viral load in the CSF during terminal infection and the CSF:plasma ratio of monocyte chemoattractant protein (MCP)-1 are strong predictors of the severity of encephalitis. Many key questions pertaining to persistence of latent viral DNA in the CNS in the asymptomatic phase of infection and selective replication of macrophage-tropic, neurovirulent viral strains during terminal stage of CNS disease have been answered using this accelerated model.
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The other accelerated model of SIV infection involves the use of antibody-mediated depletion of CD8
+ T lymphocytes, which results in the accumulation of monocytes/macrophages in the CNS early after infection, rapid disease progression, and severe SIVE (Clements et al, 2002; Craig et al, 1997; Zink et al, 1999 ). This accelerated model of SIV infection in rhesus macaques eliminated CD8 + T lymphocytes during chronic SIV infection, resulting in a rapid and marked increase in viremia that was again suppressed coinciding with the reappearance of SIVspecific CD8 + T cells. (Schmitz et al, 1999a) .
SHIV infection in macaques
Although SIV-infected macaques have been critical in our understanding of lentiviral neuropathogenesis, the genetic relatedness of these viruses is more to HIV-2 than HIV-1, especially in the env gene, which raises the question of whether these models accurately mimic the neuropathogenesis of HIV-1 infection. The construction of the chimeric of SHIV has led to significant advances in the field of AIDS, particularly in the study of immune response and vaccine development. It was necessary to establish an animal model system of AIDS that not only reflected the variety of cells, organs, and tissues afflicted, but could exhibit the immune responses typical to HIV-1 infection in humans (Joag, 2000) . In general, SHIVs are created by combining the HIV-1 envelope gene env and accessory genes tat, rev, and vpu with the SIV mac genome, including the gag and pol SIV genes (Joag, 2000) . When the SHIV/macaque model first started being utilized, there was a discrepancy between animal infectability and the development of disease. The macaques inoculated with SHIV, though infected, failed to show clinical or pathological signs of the disease (Joag, 2000; Joag et al, 1996) . The discovery that serial passaging of SHIV in the bone marrow of infected macaques, and/or animal-to-animal passaging, could produce pathogenic SHIV revolutionized exploitation of the SHIV/macaque model (Joag et al, 1996) . Such innovation has led to the development of several strains and variations of SHIV, each one with specific characteristics in regard to pathogenic phenotype that make it convenient for studying certain aspects of AIDS progression. SHIV infection in macaques creates a model system closely resembling the disease course of human AIDS. In most cases, within a number weeks the infected macaque will demonstrate a depletion of CD4 + T lymphocytes, leading to the occurrence of AIDS in a time frame of a few weeks to 2 years (Joag, 2000) . Another key feature of the SHIV/macaque model is that the pathology of certain tissues and organ systems, such as the CNS, are compatible with the corresponding pathological changes seen in human AIDS. This underscores the utility of SHIV in examining specific HIV-1-induced disease pathology, such as encephalitis, making SHIV an essential model for the study of neuro AIDS (Joag, 2000) .
There are two main categories of SHIVs partitioned into coreceptor usage: CXCR4 (X4)-or CCR5 (R5)-tropic, and dual (X4/R5)-tropic, depending on the specificity of the HIV-1 clone used in the creation of the chimera. It has been reported that X4-and R5-tropic SHIVs have differential pathogenic routes, with X4-tropic viruses causing a substantial loss of T lymphocytes in the periphery, whereas R5/dualtropic viruses negatively impact the T-cell count first in the gut, then gradually deplete the numbers in the periphery (Harouse et al, 1999) . The most widely recognized SHIVs with X4-tropic HIV-1 genes are the KU-1, KU-2, SIV agm /HIV-1, and RT-SHIV. Both SHIV KU−1/2 were constructed on a SIV mac293 genomic background with the env, tat, rev, and vpu genes of HIV-1 HXBc2, an X4-tropic virus (Joag et al, 1996 Liu et al, 1999) . The SHIV KU−1 and SHIV KU−2 pathogenic viruses can cause a decrease in the CD4 + T-lymphocyte count and the development of AIDS in macaques in 1 year with associated diseases such as pneumonia, encephalitis, and other opportunistic pathogens (Joag et al, 1996 Liu et al, 1999) . Examination of archival tissues from macaques infected with SHIV KU−2 showed that of 14 infected rhesus macaques that developed AIDS, 10 had neuropathological changes with clear evidence of virus replication in macrophages in the brain. In contrast, of 22 infected pig-tailed macaques that developed AIDS, 21 had no evidence of SHIV KU−2 replication in the brain. This difference in susceptibility to CNS disease caused by SHIV KU−2 in the two macaque species provides a novel system to further explore R Williams et al mechanisms of lentiviral neuropathogenesis (Joag et al, 1996 Liu et al, 1999) .
Different from the KU-1 and KU-2 SHIVs, the SIV agm /HIV-1 construct was created with the HIV-1 molecular clone NL4.3 (and variations thereof) in combination with SIV agm (Shibata et al, 1990 (Shibata et al, , 1991 instead of SIV mac 293. The reverse transcriptase (RT)-SHIV system is atypical from other SHIVs in that it replaces only the SIV mac239 reverse transcriptase with that of the HIV-1 clone HXBc2, without inclusion of any of the other HIV-1 genes. This model system is essentially used for testing the effectiveness of pharmaceutical drugs targeting the reverse transcriptase activity (North et al, 2005; Soderberg et al, 2002; Uberla et al, 1995) .
In the pool of R5/dual-tropic SHIVs, there are two main model systems, SHIV 89.6P and SHIV SF162 . Both constructs are based on a SIV mac239 background; however, SHIV 89.6P (and its variants) use an isolate of HIV-1 from an AIDS patient (HIV-1 89.6 ) (Karlsson et al, 1997; Reimann et al, 1996) , whereas SHIV SF162 has a HIV-1 SF162 counterpart (Luciw et al, 1995; Harouse et al, 1999 Harouse et al, , 2001 ). These models are pertinent systems when examining NeuroAIDS due to their enhanced ability to infect macrophages and microglia, the only known resident cell types within the CNS capable of sustaining productive HIV-1 infection.
In studying a model system for HIVE, the development of neuropathology is the rate-limiting feature, and not all SHIVs are created equal when using this criteria as a delimiting factor. For example, in examining pig-tailed macaques infected with SHIV KU−1 , no viral infection or pathology was found in the CNS (Buch et al, 2002; Raghavan et al, 1997) . These results are in contrast to the findings of rhesus macaques subjected to SHIV KU−2 infection, where a majority of the animals displayed productive SHIV replication in the brain associated with focal multinucleated giant cells and nodular, demyelinating lesionsneuropathology associated with HIVE (Buch et al, 2002; Raghavan et al, 1997) .
In a head to head study comparing SHIV KU to SHIV 89.6P in respect to the development of neuropathogenesis, results pointed towards SHIV 89.6P for more consistently leading to the development of neuropathology linked to HIV-1-associated CNS disease (Buch et al, 2000) . The SHIV 89.6P -infected macaques that developed encephalitis displayed activated astrocytes and microglia, multinucleated giant cells, nodular lesions of microglia, and macrophages harboring viral RNA. The SHIV KU -infected macaques sustained a progressive, yet slow, infection of the CNS; however, they lacked typical neuropathology and productively infected macrophages were not found (Buch et al, 2000) . However, baboons infected with either SHIV KU or SHIV 89.6P demonstrated productive infection of microglia (Kanmogne et al, 2002) . Another study has demonstrated that the presence of IL-4 is necessary for the induction of neuropathology in X4-tropic strains of SHIV (Buch et al, 2004b) .
The inherent differences between strains of SHIV could lead to the differential development of CNS disease. Although both viruses can take advantage of the CXCR4 coreceptor, SHIV 89.6P is also adept at utilizing the CCR5 coreceptor, a receptor found on macrophages and microglia, perhaps enhancing its innate neurovirulence (Buch et al, 2000) . Such results underscore the importance of host species and viral construct in the study of specific aspects of a disease.
After the confirmation of SHIV-dependent neurological disease in the macaque animal model, the mechanisms by which SHIV exerts its neurovirulence were investigated. One SHIV/macaque model demonstrated blood-brain barrier (BBB) perturbation after 2 weeks of SHIV infection. Specifically, the expression of the tight junction protein zonula occludens, which plays an integral role in BBB integrity, was significantly decreased .
The current thinking on HIV-1-associated CNS disease is that it is the consequence of the interplay between HIV-1/viral proteins and host immune factors, resulting in the dysregulation of cytokines/chemokines, which in turn leads to the neuropathological manifestation of the disease (Buch et al, 2004a; Sui et al, 2003) . Therefore, much emphasis has been placed on determining which host immune factors in SHIVE macaques are imbalanced as compared to those in control animals. A microarray analysis of brain tissue from SHIV 89.6P encephalitic macaques revealed a significant up-regulation of several cytokines and chemokines, including IL-4, MCP-1, and interferon-inducible peptide-10 (IP-10/CXCL10) (Buch et al, 2004a; Sui et al, 2003) . These genes all have the capability to regulate immune cell influx to the CNS, and when up-regulated can lead to the neuroinvasion typical of HIVE pathology (Sui et al, 2003) . On the opposite spectrum, growth factors, such as brain-derived growth factor (BDNF), necessary for maintaining the sensitive neuronal environment, were down-regulated in SHIVE macaques (Sui et al, 2003) . However, the expression of another growth factor, the platelet-derived growth factor B chain (PDGF-B), was found to be increased in the brains of SHIV KU−2 encephalitic macaques in a separate study (Potula et al, 2004) .
Additionally, a neurovirulent SHIV KU−1 variant derived from a macaque that developed neurological disease has been used in several studies (Singh et al, 2001 (Singh et al, , 2002 Stephens et al, 2006) . This strain of SHIV, with a nonfunctional vpu gene and mutations in the env and nef genes, is capable of causing astrocytosis (Singh et al, 2002 , along with upregulating several genes, including IL-6 and cripto-1, in the brains of the infected macaques (Singh et al, 2001 ). IL-6 can have immunoregulatory properties concerning microglia and astroglia activation, which contribute to neuroinflammation in the diseased brain. Cripto-1, which has neuroprotective properties, has been shown to colocalize with neurons during viral assault on the CNS, perhaps representing a neuronal survival mechanism (Stephens et al, 2006) . Such a wide range of host responses that are species and viral strain dependent only emphasize the delicate balance between disease states and normal CNS functioning in the complex battle between host and virus during SHIVE. To delineate such complexities for the use of therapies, vaccine or otherwise, is of the foremost importance and the reason why the SHIV/macaque model system is so valuable.
Conclusion
In summary, the SIV and SHIV macaque models of HIV infection have shown that the virus invades the brain early during the systemic infection, and that CNS infection is mediated by infected mononuclear cells and T cells that cross the blood brain barrier. Though the study of HAD is ongoing, the exact cellular and molecular mechanisms by which the disease progresses are still uncertain. The SIV and SHIV animal model systems have shed light on a multitude of viral and host factor functions and interactions during both active and latent infection. More recently, the SIV-infected macaques continue to enhance our understanding of how drugs of abuse can synergize with the virus to accelerate the development of SIV-induced encephalitis (Marcario et al, 2008) . With key differences in disease progression and neuropathology, selection of the appropriate animal model for the hypothesis in question is of critical importance. Already, studies using pertinent macaque model systems have demonstrated both the effectiveness and the shortcomings of therapies targeting immune activation in the CNS. With the use of both the SIV and the SHIV macaque model systems, scientists are advancing the fields of Neuro Virology and neuroimmune pharmacology in their quest to unlock the mysteries of HIV-associated neurocognitive disorders. 
